Selcia Appoints Simon Saxby as CEO and Andreas Rummelt to its Board

24-Feb-2011 - United Kingdom

Selcia appointed Simon Saxby as its Chief Executive Officer (CEO). He will assume his position in April and takes over from Dr Hans Fliri who retains his role as Chairman of the Board. Selcia also announce the appointment of Dr Andreas Rummelt as a Non-Executive Director.

Simon Saxby was until recently Vice-President Biologics of Recipharm Cobra Biologics prior to that he was CEO of Cobra Biomanufacturing PLC (from 2008). He has 25 years experience in the biotechnology industry, including positions as CEO of Alpha Biologics Sdn Bhd, a Malaysian contract manufacturing organisation. Simon was also founder of Murex Diagnostics, which was sold to Abbott Laboratories, and a co-founder and operations director of Quantum Biosystems Ltd. He has led the development of a CMO business for Unisyn Technologies in Massachusetts, USA for 4 years and has held appointments with KS Biomedix Plc, Xenova Plc and Scynexis Europe Ltd.

Dr Rummelt is Partner and CEO of InterPharmaLink AG, Basel, and has more than 25 years of experience in the pharmaceutical industry, notably in drug development, technical operations, quality assurance, global manufacturing and generics. Dr Rummelt was a member of the Executive Committee of Novartis from 2006 to 2010, where he most recently served as Group Head of Quality Assurance and Technical Operations until his resignation in 2010. Dr Rummelt joined Sandoz Pharma Ltd in Switzerland in 1985 and held various positions of increasing responsibility in drug development, lastly as Global Head of Technical Research & Development. From 1999 to 2004, Dr Rummelt served as Global Head of Technical Operations of the Novartis Pharmaceuticals Division. From 2004 to 2008, he was CEO of Sandoz, the generics division of Novartis. Andreas Rummelt is also a member of the Board of Directors of Alexion Pharmaceuticals, USA (NASDAQ) and Famar Health Care Services, GR. Dr Rummelt gained his PhD in Pharmaceutical Sciences from the University of Erlangen-Nuremberg, Germany.

https://www.bionity.com/en/news/130987/selcia-appoints-simon-saxby-as-ceo-and-andreas-rummelt-to-its-board.html